Associate Professor of Medicine, University Ariz College of Medicine
Hematology
Dr. Alison T. Stopeck, MD
|
|
Give Review
Alison Stopeck practices Hematology. She studied medicine at Columbia University College of Physicians & Surgeons. Columbia University College of Physicians & Surgeons is a top medical university. Columbia University College of Physicians & Surgeons is ranked 8 in research and 52 in primary care medicine Alison Stopeck is a published physician as well. She has 35 publications published. The latest was: Erratum to: Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate c... She accepts Medicare.
Publications
- Pain and analgesic use associated with skeletal-related events in patients with advanced Cancer and bone metastases.
- Erratum to: Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic Breast and prostate c...
- Automated Breast segmentation of fat and water MR images using dynamic programming.
- Assessment of carbonic anhydrase IX expression and extracellular pH in B-cell Lymphoma cell line models.
- A Pilot Study of Estradiol Followed by Exemestane for Reversing Endocrine Resistance in Postmenopausal Women With Hormone Receptor-Positive Metastatic Breast Cancer.
- Isolation of viable Cancer cells in antibody-functionalized microfluidic devices.
- Reply to Araki et al.
- Pain outcomes in patients with advanced breast Cancer and bone metastases: Results from a randomized, double-blind study of denosumab and zoledronic acid.
- Prevalence of depression in adults with haemophilia.
- Task-based evaluation of segmentation algorithms for diffusion-weighted MRI without using a gold standard.
- A phase II trial of standard dose cyclophosphamide, doxorubicin, vincristine, prednisone (CHOP) and rituximab plus bevacizumab for patients with newly diagnosed diffus...
- The role of targeted therapy and biomarkers in breast Cancer treatment.
- Role of denosumab in the management of skeletal complications in patients with bone metastases from solid Tumors.
- Cost-effectiveness of denosumab vs zoledronic acid for prevention of skeletal-related events in patients with solid tumors and bone metastases in the United States.
- A phase II study of lapatinib and bevacizumab as treatment for HER2-overexpressing metastatic breast Cancer.
- Phase I Safety and Pharmacokinetic Study of Bavituximab, a Chimeric Phosphatidylserine-Targeting Monoclonal Antibody, in Patients with Advanced Solid Tumors.
- How Do We Define Efficacy in Comparing Osteoclast-Targeted Agents in Metastatic Breast Cancer?
- HSP90 inhibition is effective in breast Cancer: a phase II trial of tanespimycin (17-AAG) plus trastuzumab in patients with HER2-positive metastatic breast Cancer prog...
- Randomized, Placebo-Controlled, Double-Blind, Phase II Study of Axitinib Plus Docetaxel Versus Docetaxel Plus Placebo in Patients With Metastatic Breast Cancer.
- Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast Cancer: a randomized, double-blind study.
- Caring for the breast Cancer survivor: a guide for primary care physicians.
- A Clustering Algorithm for Liver Lesion Segmentation of Diffusion-Weighted MR Images.
- Evaluating segmentation algorithms for diffusion-weighted MR images: a task-based approach.
- Sulindac and sulindac metabolites in nipple aspirate fluid and effect on drug targets in a phase I trial.
- A phase 1 trial of 2 dose schedules of ABT-510, an antiangiogenic, thrombospondin-1-mimetic peptide, in patients with advanced Cancer.
- Combination of trastuzumab and tanespimycin (17-AAG, KOS-953) is safe and active in trastuzumab-refractory HER-2 overexpressing breast Cancer: a phase I dose-escalatio...
- Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage Acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Grou...
- Women's health: the struggle to restore hormonal balance.
- SU5416, a small molecule tyrosine kinase receptor inhibitor, has biologic activity in patients with refractory Acute myeloid leukemia or myelodysplastic syndromes.
- Phase II study of SU5416--a small-molecule, vascular endothelial growth factor tyrosine-kinase receptor inhibitor--in patients with refractory Myeloproliferative disea...
- Antigen-driven oligoclonal expansion of tumor-infiltrating B cells in infiltrating ductal carcinoma of the Breast.
- Radial fast spin-echo method for T2-weighted imaging and T2 mapping of the Liver.
- Utilities associated with subcutaneous injections and intravenous infusions for treatment of patients with bone metastases.
- Impact of denosumab on bone mass in Cancer patients.
Schools
Columbia University College Of Physicians and Surgeons
Colum Presby Med Center
New York Hospital
Procedures Preformed
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- Plasmapheresis
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Education
-
New York Presbyterian Hospital - Cornell Campus -
New York Presbyterian Hospital - Columbia Campus -
Columbia University College of Physicians & Surgeons
Hospital
-
Stony Brook University Medical Center
Drug Facts
| NPI NUMBER | 1144392291 | |
| NPPES Provider LastName | STOPECK | |
| NPPES Provider FirstName | ALISON | |
| NPPES Provider ZIPCode | 857067124 | |
| NPPES Provider State | AZ | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 147.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1144392291 |
| Last Name Of The Provider | STOPECK |
| First Name Of The Provider | ALISON |
| View All |
Similar Doctors
|
Dr. Parminder Singh, MD |
|
|
Dr. Michael A. Boxer, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert B. Livingston, MD |
|
|
Dr. Emad Elquza, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lee D. Cranmer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rashad A. Aboul-Nasr, MD |
|
|
Dr. Ted W. Keyes, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sarah G. McGinn, MD |
|
|
Dr. Lisa M. Rimsza, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Deborah A. Fuchs, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mehrnoosh Zarkoob, MD |
|
|
Dr. Quentin S. Ringenberg, MD |
|
|
Dr. Robert J. Brooks, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Manuel Modiano, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Soham D. Puvvada, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Veronique Poulin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christopher C. Chen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ana M. Lopez, MD |
|
|
Dr. Natalie A. Swansen, MD
This Doctor is OpenDoctor Recommended.
|